期刊文献+

根除幽门螺杆菌治疗免疫性血小板减少症

The observation of anti-Helicobacter pylori treatment in Immune thrombocytopenia disease
暂未订购
导出
摘要 目的:比较糖皮质激素联合幽门螺杆菌(Hp)根除疗法与单用糖皮质激素治疗免疫性血小板减少症(ITP)患者的临床疗效。方法:选择安庆市第一人民医院门诊或住院幽门螺杆菌阳性的符合ITP诊断标准患者62例,随机分为治疗组和对照组,治疗组糖皮质激素联合Hp根除疗法;对照组单用糖皮质激素;观察疗效6个月。结果:治疗组总有效率为87.1%,对照组总有效率为48.4%,差异有统计学意义(P<0.05)。结论:糖皮质激素联合幽门螺杆菌根除疗法对ITP的治疗效果显著,是一种值得推广的方法。 Objective:Compare the clinical curative egiciency between the group of glucocorticoid combined with Hp eradication and the glucocoticoid group in Immune thrombocytopenia patients.Methods:62 patients with ITP diag-nostic criteria was randomly divided into the combined treatment group (glucocorticoid+Hp eradication) and the glu- cocorticoid group (glucocorticoid).6 monthes later, observe the clinic effect.Results:The effect of the combined treat-ment group was 87.1% while the glucocorticoid group was 48.4% .There was significant difference between two groups(P〈O.O5).Conclusion:glucocorticoid therapy combined with Hp eradication is effective for idiopathic thrombo-cytopenic purpura patients with Hp and this treatment is worth popularization for these patients.
出处 《安徽卫生职业技术学院学报》 2013年第5期17-17,25,共2页 Journal of Anhui Health Vocational & Technical College
关键词 幽门螺杆菌 根除 免疫性血小板减少症 疗效 Eradication Helicobacter pylori Idiopathic th-rombocytopenic purpura Curative effect
  • 相关文献

参考文献4

二级参考文献27

  • 1Gasbarrini A, Franceschi F, Tartaglione R, et al. Regression of autoimmune thrombocytopenia after eradication of Helicobacter pylori[ J]. Lancet, 1998, 352(9131 ) :878.
  • 2Takahashi T, Yujiri T, Tanizawa Y. Helicobacter pylori and chronic ITP: the discrepancy in the clinical responses to eradication therapy might be due to differences in the bacterial strains [J].Blood, 2004, 104 (2) :594.
  • 3Franchini M, Veneri D. Helicobacter pylori-associated immune thrombocytopenia[J]. Platelets, 2006 , 17 (2) :71 - 77.
  • 4Suzuki T, Matsushima M, Masui A, et al. Ettect of Helicobacter priori eradication in patients with chronic idiopathic thrombocytopenic purpura-a randomized controlled trial [J]. Am J Gastroenterol, 2005,100(6) :1265 -1270.
  • 5Stasi R, Sarpatwari A, Segal JB, et al. Effects of eradication of Helicobacter pylori infection in patients with immune thrombocytopenic purpura: a systematic review[J]. Blood, 2009, 113 (6) : 1231 - 1240.
  • 6Jarque I, Andreu R, Llopis I, et al. Absence of platelet response after eradication of Helicobacter pylori infection in patients with chronic idiopathic thrombocytopenic purpura [ J ]. Br J Haematol, 2001, 115 (4) : 1002 - 1003.
  • 7Michel M, Cooper N, Jean C, et al. Does Helicobater pylori initiate or perpetuate immune thrombocytopenic purpura[J].Blood, 2004,103(3):890 -896.
  • 8Takahashi T, Yujiri T, Shinohara K, et al. Moleucular mimiery by Helicobaeter pylori eagA protein may be involved in the pathogenesis of Helicobacter pylori-associated chronic idiopathic thrombocytopenic purpura [ J ]. Br J Haematol,2004,124( 1 ) :91 - 96.
  • 9Michel M, Khellaf M, Desforgges L, et al. Autoimmune thrombocytopenic purpura and Helicobacter pylori infection[J]. Arch Intern Med,2002,162(9) :1033 - 1036.
  • 10Perez-Perez GI, Bhat N, Gaensbaure J, et al. Countryspecific constancy by age in cagA^+ proportion of Helicobacter pylori infection [ J ]. Int J Cancer, 1997,72 ( 3 ) : 453 - 456.

共引文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部